AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%

Shares of AbbVie Inc. ABBV, -1.17% were up 1.9% in premarket trading on Thursday after the drugmaker beat expectations for the quarter. The company had a loss of $739 million, or 46 cents per share, in the second quarter of 2020.